Schistosomes: The road from host-parasite interactions to vaccines in clinical trials

Trends in Parasitology

Volumn 21, Issue 3, 2005, Pages 143-149

  Capron, André ^a   Riveau, Gilles ^a   Capron, Monique ^a   Trottein, François ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; SCHISTOSOMA VACCINE;

CLINICAL TRIAL; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVITY; HOST PARASITE INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; REVIEW; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SIDE EFFECT; TH2 CELL; TOXICITY TESTING; VACCINE PRODUCTION;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; VERMES;

EID: 13944268373     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.01.003     Document Type: Review

References (71)

1. C.G. Mascie-Taylor, and E. Karim The burden of chronic disease Science 302 2003 1921 1922
2. R. Bergquist Prospects for schistosomiasis vaccine development TDR News 71 2004 6
3. M.S. Chan Human schistosomiasis: potential long-term consequences of vaccination programmes Vaccine 15 1997 1545 1550
4. J.M. Balloul Molecular cloning of a protective antigen of schistosomes Nature 326 1987 149 153
5. E.J. Pearce, and A.S. MacDonald The immunobiology of schistosomiasis Nat. Rev. Immunol. 2 2002 499 511
6. R.M. Maizels, and M. Yazdanbakhsh Immune regulation by helminth parasites: cellular and molecular mechanisms Nat. Rev. Immunol. 9 2003 733 744
7. M. Hesse The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells J. Immunol. 172 2004 3157 3166
8. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development J. Immunol. 173 2004 1224 1231
9. D.R. Herbert Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology Immunity 20 2004 623 635
10. P. Smith Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages J. Immunol. 173 2004 1240 1248
11. I. Wickelgren Can worms tame the immune system? Science 305 2004 170 171
12. D.L. Boros T helper cell populations, cytokine dynamics, and pathology of the schistosome egg granuloma Microbes Infect. 1 1999 511 519
13. D. van der Kleij, and M. Yazdanbakhsh Control of inflammatory diseases by pathogens: lipids and the immune system Eur. J. Immunol. 33 2003 2953 2963
14. P.G. Thomas, and D.A. Harn Immune biasing by helminth glycans Cell. Microbiol. 6 2004 13 22
15. P. Velupillai Interleukin-12 and -10 and gamma interferon regulate polyclonal and ligand-specific expansion of murine B-1 cells Infect. Immun. 64 1996 4557 4560
16. G. Schramm Molecular characterization of an IL-4-inducing factor from Schistosoma mansoni eggs J. Biol. Chem. 278 2003 18384 18392
17. C. Faveeuw Role of the CD1d-mediated antigen presentation of parasite glycoconjugates in the induction of type 2 responses during murine schistosomiasis J. Immunol. 169 2002 906 912
18. P. Zaccone Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes Eur. J. Immunol. 33 2003 1439 1449
19. M. Kronenberg, and L. Gapin The unconventional lifestyle of NKT cells Nat. Rev. Immunol. 2 2002 557 568
20. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 248
21. R. Medzhitov, and C.A. Janeway Innate immunity: impact on the adaptive immune response Curr. Opin. Immunol. 9 1997 4 9
22. K. Dabbagh, and D.B. Lewis Toll-like receptors and Th1/Th2 responses Curr. Opin. Infect. Dis. 16 2003 199 204
23. D. Jankovic Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways Trends Immunol. 22 2001 450 457
24. S. Agrawal Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos J. Immunol. 171 2003 4984 4989
25. V. Redecke Activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma J. Immunol. 172 2004 2739 2743
26. T.B. Geijtenbeek Mycobacteria target DC-SIGN to suppress dendritic cell function J. Exp. Med. 197 2003 7 17
27. L. Cervi Dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses J. Immunol. 172 2004 2016 2020
28. P. Ricciardi-Castagnoli, and F. Granucci Interpretation of the complexity of innate immune responses by functional genomics Nat. Rev. Immunol. 2 2002 881 889
29. F. Trottein A type I IFN-dependent pathway induced by Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an inflammatory signature J. Immunol. 172 2004 3011 3017
30. D. van der Kleij A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization J. Biol. Chem. 277 2002 48122 48129
31. P.G. Thomas Maturation of dendritic cell 2 phenotype by a helminth glycan uses a toll-like receptor 4-dependent mechanism J. Immunol. 171 2003 5837 5841
32. I. van Die The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x Glycobiology 13 2003 471 478
33. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection J. Exp. Med. 193 2001 1135 1147
34. 2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni J. Immunol. 165 2000 4567 4574
35. 2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion Eur. J. Immunol. 33 2003 2764 2772
36. J.B. Taylor The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni EMBO J. 7 1988 465 472
37. P. Hagan Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium Nature 349 1991 243 245
38. P. Rihet Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels Eur. J. Immunol. 21 1991 2679 2686
39. M. Capron, and A. Capron Immunoglobulin E and effector cells in schistosomiasis Science 264 1994 1876 1877
40. D.W. Dunne Prospects for immunological control of schistosomiasis Lancet 345 1995 1488 1491
41. V. Rodrigues Jr Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes Infect. Immun. 67 1999 4689 4692
42. B.M. Ogilvie Reagin-like antibodies in experimental infections of Schistosoma mansoni and the passive transfer of resistance Nature 209 1966 1221 1223
43. M. Al-Sherbiny In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens Acta Trop. 88 2003 117 130
44. D. Grezel Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies Eur. J. Immunol. 23 1993 454 460
45. J.M. Grzych IgA antibodies to a protective antigen in human Schistosomiasis mansoni J. Immunol. 150 1993 527 5339
46. F. Remoué Sex-dependent neutralizing humoral responses to Schistosoma mansoni 28GST in infected human populations J. Inf. Dis. 181 2000 1855 1859
47. F. Remoué Gender-dependent specific immune response during chronic human Schistosomiasis haematobia Clin. Exp. Immunol. 124 2001 62 68
48. J.M. Grzych Blocking activity of rat monoclonal antibodies in experimental schistosomiasis J. Immunol. 133 1984 998 1004
49. C. Auriault Related antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides J. Clin. Microbiol. 28 1990 1918 1924
50. C.A. Akdis Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells J. Allergy Clin. Immunol. 99 1997 345 353
51. A. Taylor T regulatory cells in allergy and health: a question of allergen specificity and balance Int. Arch. Allergy Immunol. 135 2004 73 82
52. T.A. Platts-Mills Serum IgG and IgG4 antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response Int. Arch. Allergy Immunol. 124 2001 126 129
53. M. Pretolani, and M. Goldman IL-10: a potential therapy for allergic inflammation? Immunol. Today 18 1997 277 280
54. C.L. King Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset J. Clin. Invest. 92 1993 1667 1673
55. M. Wills-Karp The germless theory of allergic disease: revisiting the hygiene hypothesis Nat. Rev. Immunol. 1 2001 69 75
56. M. Yazdanbakhsh Allergy, parasites, and the hygiene hypothesis Science 296 2002 490 494
57. J.F. Bach The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med. 347 2002 911 920
58. A.J. Fulford Puberty and age-related changes in susceptibility to schistosome infection Parasitol. Today 14 1998 23 26
59. J.M. Grzych Relationship of impairment of schistosome 28-kilodalton GST activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST Infect. Immun. 66 1998 1142 1148
60. D. Boulanger Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni Parasite Immunol. 13 1991 473 490
61. M.G. Taylor Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host Vaccine 16 1998 1290 1298
62. D. Boulanger Vaccine potential of a recombinant glutathione S-transferase cloned from Schistosoma haematobium in primates experimentally infected with an homologous challenge Vaccine 17 1999 319 326
63. J.C. Scott, and D.P. McManus Molecular cloning and enzymatic expression of the 28-kDa glutathione S-transferase of Schistosoma japonicum: evidence for sequence variation but lack of consistent vaccine efficacy in the murine host Parasitol. Int. 49 2000 289 300
64. F. Shi Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China Vaccine 20 2001 462 467
65. M.A. Lebens Mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection Vaccine 21 2003 514 520
66. C.B. Xu Schistosoma mansoni 28-kDa GST and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domains J. Immunol. 150 1993 940 949
67. D. Boulanger Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant GST cloned from S. mansoni Parasite Immunol. 17 1995 361 369
68. K.A. Johnson A crystal structure of the 28 kDa glutathione S-transferase from Schistosoma haematobium Biochemistry 42 2003 10084 10094
69. A. Capron Vaccine development against schistosomiasis from concepts to clinical trials Br. Med. Bull. 62 2002 139 148
70. F. Mutati Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection J. Infect. Dis. 178 1998 289 293
71. L. Dupré Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment J. Infect. Dis. 180 1999 454 463